15 October 2026

INSIGHT 2026 Concludes with Two Days of Scientific Exchange and Innovation

Experts from academia and industry gathered in Dublin for the inaugural INSIGHT 2026 conference, exploring advances in pharmaceutical testing, automation, digitalization, and complex dosage forms.

After two days in Dublin, INSIGHT 2026 has successfully concluded its inaugural edition, bringing together pharmaceutical scientists, industry experts, innovators, and decision-makers from around the world.

The conference provided a platform to discuss developments shaping the future of pharmaceutical testing across R&D and Quality Control. Attendees explored a broad range of topics, including dissolution science, predictive modeling, laboratory automation, digitalization, release testing, and the challenges associated with complex dosage forms. Scientific presentations, case studies, and interactive workshops created opportunities for learning, discussion, and exchange.

A particular strength of INSIGHT 2026 was the interaction between academia and industry. Internationally recognized experts shared their knowledge and perspectives, while participants contributed through questions, discussions, and networking throughout the event.

Beyond the scientific program, INSIGHT 2026 highlighted the value of bringing together different perspectives to discuss shared challenges and future opportunities in pharmaceutical testing. The high level of engagement from speakers, participants, partners, and sponsors helped establish a strong foundation for future editions of the conference.

While the inaugural event in Dublin has come to a close, the conversations and connections established over the past two days will continue well beyond the conference itself.

The INSIGHT community will reunite at INSIGHT 2027, taking place in Boston, USA, on 29-30 September 2027. Save the date.